🔎 Trials Near Me

Acasă › Neuroblastom › Colorado

Studii clinice pentru Neuroblastom în Colorado

8 studii pentru Neuroblastom caută participanți în Colorado.

Orașe în Colorado

Text oficial al studiului (în engleză)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Hospital Colorado, Aurora
În curs de recrutareFaza 3
Până la vârsta de 30 · Toate sexele · Actualizat 2 oct. 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora
În curs de recrutareFaza 1/2
6 Months – 25 Years · Toate sexele · Actualizat 17 sept. 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Hospital Colorado, Aurora
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
În curs de recrutareFaza 3
365 Days – 30 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Colorado, Aurora
În curs de recrutareFaza 1/2
12 Months – 30 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  • Children's Hospital Colorado, Aurora
În curs de recrutareFaza 2
Vârste de la 1 la 31 · Toate sexele · Actualizat 20 iul. 2026 · NCT06450041

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's Hospital Colorado, Aurora
În curs de recrutareFaza 1/2
12 Months – 30 Years · Toate sexele · Actualizat 19 mai 2026 · NCT04901702

Neuroblastoma Biology Study

  • Children Hospital of Colorado, Aurora
În curs de recrutareStudiu observațional
31 Days – 99 Years · Toate sexele · Actualizat 23 mar. 2026 · NCT01587300

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital of Colorado, Aurora
În curs de recrutareFaza 2
18 Months – 40 Years · Toate sexele · Actualizat 12 aug. 2025 · NCT05135975

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.